<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36922030</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>06</Day></DateRevised><Article PubModel="Electronic-Print"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Monocyte migration profiles define disease severity in acute COVID-19 and unique features of long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2202226</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.02226-2022</ELocationID><Abstract><AbstractText Label="BACKGROUND">COVID-19 is associated with a dysregulated immune response but it is unclear how immune dysfunction contributes to the chronic morbidity persisting in many COVID-19 patients during convalescence (long COVID).</AbstractText><AbstractText Label="METHODS">We assessed phenotypical and functional changes of monocytes in COVID-19 patients during hospitalisation and up to 9&#x2005;months of convalescence following COVID-19, respiratory syncytial virus or influenza A. Patients with progressive fibrosing interstitial lung disease were included as a positive control for severe, ongoing lung injury.</AbstractText><AbstractText Label="RESULTS">Monocyte alterations in acute COVID-19 patients included aberrant expression of leukocyte migration molecules, continuing into convalescence (n=142) and corresponding with specific symptoms of long COVID. Long COVID patients with unresolved lung injury, indicated by sustained shortness of breath and abnormal chest radiology, were defined by high monocyte expression of C-X-C motif chemokine receptor 6 (CXCR6) (p&lt;0.0001) and adhesion molecule P-selectin glycoprotein ligand 1 (p&lt;0.01), alongside preferential migration of monocytes towards the CXCR6 ligand C-X-C motif chemokine ligand 16 (CXCL16) (p&lt;0.05), which is abundantly expressed in the lung. Monocyte CXCR6 and lung CXCL16 were heightened in patients with progressive fibrosing interstitial lung disease (p&lt;0.001), confirming a role for the CXCR6-CXCL16 axis in ongoing lung injury. Conversely, monocytes from long COVID patients with ongoing fatigue exhibited a sustained reduction of the prostaglandin-generating enzyme cyclooxygenase 2 (p&lt;0.01) and CXCR2 expression (p&lt;0.05). These monocyte changes were not present in respiratory syncytial virus or influenza A convalescence.</AbstractText><AbstractText Label="CONCLUSIONS">Our data define unique monocyte signatures that define subgroups of long COVID patients, indicating a key role for monocyte migration in COVID-19 pathophysiology. Targeting these pathways may provide novel therapeutic opportunities in COVID-19 patients with persistent morbidity.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Nicholas A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0003-3161-3216</Identifier><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pearmain</LastName><ForeName>Laurence</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1288-3026</Identifier><AffiliationInfo><Affiliation>North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Equal contribution.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>Sean B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brand</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morgan</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0002-5085-4093</Identifier><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagger</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harbach</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Saba</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shuwa</LastName><ForeName>Halima A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Franklin</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>K&#xe4;stele</LastName><ForeName>Verena</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prise</LastName><ForeName>Ian</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClure</LastName><ForeName>Flora A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hackney</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Research Innovation, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Lara</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Research Innovation, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Menon</LastName><ForeName>Madhvi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Konkel</LastName><ForeName>Joanne E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lawless</LastName><ForeName>Criag</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Regional Infectious Diseases Unit, North Manchester General Hospital, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, Salford Royal NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mathioudakis</LastName><ForeName>Alexander G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanel</LastName><ForeName>Stefan C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ustianowski</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Regional Infectious Diseases Unit, North Manchester General Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindergard</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Regional Infectious Diseases Unit, North Manchester General Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brij</LastName><ForeName>Seema</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Manchester Royal Infirmary, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diar Bakerly</LastName><ForeName>Nawar</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0003-2102-1997</Identifier><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dark</LastName><ForeName>Paul</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Salford Royal NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brightling</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, Leicester NIHR BRC, University of Leicester, Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rivera-Ortega</LastName><ForeName>Pilar</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lord</LastName><ForeName>Graham M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horsley</LastName><ForeName>Alex</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1828-0058</Identifier><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>CIRCO</CollectiveName></Author><Author ValidYN="Y"><LastName>Piper Hanley</LastName><ForeName>Karen</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Diabetes, Endocrinology and Gastroenterology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Felton</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Infection, Immunity and Respiratory Medicine, Manchester NIHR BRC, Education and Research Centre, Wythenshawe Hospital, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grainger</LastName><ForeName>John R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-4052-5923</Identifier><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint senior authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussell</LastName><ForeName>Tracy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint senior authors.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mann</LastName><ForeName>Elizabeth R</ForeName><Initials>ER</Initials><AffiliationInfo><Affiliation>Lydia Becker Institute of Immunology and Inflammation, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK elizabeth.mann@manchester.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maternal and Fetal Health Centre, Division of Developmental Biology, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Joint senior authors.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>202865/Z/16/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/L011840/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/P023541/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/R00191X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019743">Chemokines, CXC</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011991">Receptors, Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075744">Receptors, CXCR6</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D019707">Receptors, Chemokine</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008024">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075743">Chemokine CXCL16</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2023 May 11;61(5):2300409. doi: 10.1183/13993003.00409-2023</RefSource><PMID Version="1">36958743</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019743" MajorTopicYN="N">Chemokines, CXC</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011991" MajorTopicYN="N">Receptors, Virus</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075744" MajorTopicYN="N">Receptors, CXCR6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019707" MajorTopicYN="N">Receptors, Chemokine</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055370" MajorTopicYN="Y">Lung Injury</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008024" MajorTopicYN="N">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003289" MajorTopicYN="N">Convalescence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000075743" MajorTopicYN="N">Chemokine CXCL16</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062072" MajorTopicYN="N">Patient Acuity</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Conflict of interest: G. Lindergard is co-founder and scientific advisory board member of Gritstone Bio Inc., which is a public company that develops therapeutic vaccines for the treatment of cancer and infectious diseases, including COVID-19. The other authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>15</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36922030</ArticleId><ArticleId IdType="pmc">PMC10040898</ArticleId><ArticleId IdType="doi">10.1183/13993003.02226-2022</ArticleId><ArticleId IdType="pii">13993003.02226-2022</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . World Health Organization (COVID-19) Dashboard. https://covid19.who.int/
Date last accessed: 13 April 2023.</Citation></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497&#x2013;506. doi: 10.1016/s0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann ER, Menon M, Knight SB, et al. . Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19. Sci Immunol 2020; 5: eabd6197. doi:10.1126/sciimmunol.abd6197</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd6197</ArticleId><ArticleId IdType="pmc">PMC7857390</ArticleId><ArticleId IdType="pubmed">32943497</ArticleId></ArticleIdList></Reference><Reference><Citation>Melms JC, Biermann J, Huang H, et al. . A molecular single-cell lung atlas of lethal COVID-19. Nature 2021; 595: 114&#x2013;119. doi:10.1038/s41586-021-03569-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03569-1</ArticleId><ArticleId IdType="pmc">PMC8814825</ArticleId><ArticleId IdType="pubmed">33915568</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo PA, Dogra P, Gray JI, et al. . Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity 2021; 54: 797&#x2013;814. doi:10.1016/j.immuni.2021.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.03.005</ArticleId><ArticleId IdType="pmc">PMC7951561</ArticleId><ArticleId IdType="pubmed">33765436</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte-Schrepping J, Reusch N, Paclik D, et al. . Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell 2020; 182: 1419&#x2013;1440. doi:10.1016/j.cell.2020.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.001</ArticleId><ArticleId IdType="pmc">PMC7405822</ArticleId><ArticleId IdType="pubmed">32810438</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvin A, Chapuis N, Dunsmore G, et al. . Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19. Cell 2020; 182: 1401&#x2013;1418. doi:10.1016/j.cell.2020.08.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.002</ArticleId><ArticleId IdType="pmc">PMC7405878</ArticleId><ArticleId IdType="pubmed">32810439</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, et al. . Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med 2020; 26: 842&#x2013;844. doi:10.1038/s41591-020-0901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>COMBAT Consortium . A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell 2022; 185: 916&#x2013;938. doi:10.1016/j.cell.2022.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.012</ArticleId><ArticleId IdType="pmc">PMC8776501</ArticleId><ArticleId IdType="pubmed">35216673</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsana L, Sonzogni A, Nasr A, et al. . Pulmonary post-mortem findings in a series of COVID-19 cases from Northern Italy: a two-centre descriptive study. Lancet Infect Dis 2020; 20: 1135&#x2013;1140. doi:10.1016/S1473-3099(20)30434-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30434-5</ArticleId><ArticleId IdType="pmc">PMC7279758</ArticleId><ArticleId IdType="pubmed">32526193</ArticleId></ArticleIdList></Reference><Reference><Citation>Beigmohammadi MT, Jahanbin B, Safaei M, et al. . Pathological findings of postmortem biopsies from lung, heart, and liver of 7 deceased COVID-19 patients. Int J Surg Pathol 2021; 29: 135&#x2013;145. doi:10.1177/1066896920935195</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1066896920935195</ArticleId><ArticleId IdType="pmc">PMC8041443</ArticleId><ArticleId IdType="pubmed">32552178</ArticleId></ArticleIdList></Reference><Reference><Citation>Deshmukh V, Motwani R, Kumar A, et al. . Histopathological observations in COVID-19: a systematic review. J Clin Pathol 2021; 74: 76&#x2013;83. doi:10.1136/jclinpath-2020-206995</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206995</ArticleId><ArticleId IdType="pubmed">32817204</ArticleId></ArticleIdList></Reference><Reference><Citation>Stikker BS, Stik G, van Ouwerkerk AF, et al. . Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages. Genome Biol 2022; 23: 96. doi:10.1186/s13059-022-02669-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-022-02669-z</ArticleId><ArticleId IdType="pmc">PMC9009160</ArticleId><ArticleId IdType="pubmed">35421995</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser E. Long term respiratory complications of COVID-19. BMJ 2020; 370: m3001. doi:10.1136/bmj.m3001</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3001</ArticleId><ArticleId IdType="pubmed">32747332</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams FMK, Muirhead N, Pariante C. COVID-19 and chronic fatigue. BMJ 2020; 370: m2922. doi:10.1136/bmj.m2922</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m2922</ArticleId><ArticleId IdType="pubmed">32732337</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. . Management of post-acute COVID-19 in primary care. BMJ 2020; 370: m3026. doi:10.1136/bmj.m3026</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3026</ArticleId><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>PHOSP-COVID Collaborative Group . Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med 2022; 10: 761&#x2013;775. doi:10.1016/S2213-2600(22)00127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. . Attributes and predictors of long COVID. Nat Med 2021; 27: 626&#x2013;631. doi:10.1038/s41591-021-01292-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C, Darley DR, Wilson DB, et al. . Immunological dysfunction persists for 8&#x2005;months following initial mild-to-moderate SARS-CoV-2 infection. Nat Immunol 2022; 23: 210&#x2013;216. doi:10.1038/s41590-021-01113-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M, Mildner A, Yona S. Developmental and functional heterogeneity of monocytes. Immunity 2018; 49: 595&#x2013;613. doi:10.1016/j.immuni.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.10.005</ArticleId><ArticleId IdType="pubmed">30332628</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol 2020; 20: 355&#x2013;362. doi:10.1038/s41577-020-0331-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0331-4</ArticleId><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerschaert J, Furie MB. Monocytes use either CD11/CD18 or VLA-4 to migrate across human endothelium in vitro. J Immunol 1994; 152: 1915&#x2013;1926.</Citation><ArticleIdList><ArticleId IdType="pubmed">7509831</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerschaert J, Furie MB. The adhesion molecules used by monocytes for migration across endothelium include CD11a/CD18, CD11b/CD18, and VLA-4 on monocytes and ICAM-1, VCAM-1, and other ligands on endothelium. J Immunol 1995; 154: 4099&#x2013;4112.</Citation><ArticleIdList><ArticleId IdType="pubmed">7535821</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao F, Huynh HK, Eiroa A, et al. . Migration of monocytes across endothelium and passage through extracellular matrix involve separate molecular domains of PECAM-1. J Exp Med 1995; 182: 1337&#x2013;1343. doi:10.1084/jem.182.5.1337</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.182.5.1337</ArticleId><ArticleId IdType="pmc">PMC2192210</ArticleId><ArticleId IdType="pubmed">7595204</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, et al. . Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 2020; 584: 463&#x2013;469. doi:10.1038/s41586-020-2588-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2588-y</ArticleId><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj J, Yatim N, Barnabei L, et al. . Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 2020; 369: 718&#x2013;724. doi:10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, et al. . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46: 846&#x2013;848. doi:10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldberger A, Middleton KA, Oliver JA, et al. . Biosynthesis and processing of the cell adhesion molecule PECAM-1 includes production of a soluble form. J Biol Chem 1994; 269: 17183&#x2013;17191.</Citation><ArticleIdList><ArticleId IdType="pubmed">8006026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojo Y, Ikeda U, Takahashi M, et al. . Matrix metalloproteinase-1 expression by interaction between monocytes and vascular endothelial cells. J Mol Cell Cardiol 2000; 32: 1459&#x2013;1468. doi:10.1006/jmcc.2000.1179</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/jmcc.2000.1179</ArticleId><ArticleId IdType="pubmed">10900172</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanojevic S, Kaminsky DA, Miller M, et al. . ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J 2022; 60: 2101499. doi:10.1183/13993003.01499-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01499-2021</ArticleId><ArticleId IdType="pubmed">34949706</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Chen M, Collier GJ, et al. . Hyperpolarized 129Xe MRI abnormalities in dyspneic patients 3 months after COVID-19 pneumonia: preliminary results. Radiology 2021; 301: E353&#x2013;EE60. doi:10.1148/radiol.2021210033</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210033</ArticleId><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan X, Yao L, Tan Y, et al. . Quantitative and semi-quantitative CT assessments of lung lesion burden in COVID-19 pneumonia. Sci Rep 2021; 11: 5148. doi:10.1038/s41598-021-84561-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84561-7</ArticleId><ArticleId IdType="pmc">PMC7933172</ArticleId><ArticleId IdType="pubmed">33664342</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis. Immunity 2016; 44: 450&#x2013;462. doi:10.1016/j.immuni.2016.02.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.02.015</ArticleId><ArticleId IdType="pmc">PMC4794754</ArticleId><ArticleId IdType="pubmed">26982353</ArticleId></ArticleIdList></Reference><Reference><Citation>Wendisch D, Dietrich O, Mari T, et al. . SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis. Cell 2021; 184: 6243&#x2013;6261.e27. doi:10.1016/j.cell.2021.11.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8626230</ArticleId><ArticleId IdType="pubmed">34914922</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan AJ, Guillen C, Symon FA, et al. . Expression of CXCR6 and its ligand CXCL16 in the lung in health and disease. Clin Exp Allergy 2005; 35: 1572&#x2013;1580. doi:10.1111/j.1365-2222.2005.02383.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2222.2005.02383.x</ArticleId><ArticleId IdType="pubmed">16393323</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia L, Sperandio M, Yago T, et al. . p-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest 2002; 109: 939&#x2013;950. doi:10.1172/JCI14151</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI14151</ArticleId><ArticleId IdType="pmc">PMC150926</ArticleId><ArticleId IdType="pubmed">11927621</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, Elliott J, Chadeau-Hyam M, et al. . Persistent symptoms following SARS-CoV-2 infection in a random community sample of 508, 707 people. medRxiv 2021; preprint [10.1101/2021.06.28.21259452].</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.28.21259452</ArticleId></ArticleIdList></Reference><Reference><Citation>Birnhuber A, Fliesser E, Gorkiewicz G, et al. . Between inflammation and thrombosis: endothelial cells in COVID-19. Eur Respir J 2021; 58: 2100377. doi:10.1183/13993003.00377-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00377-2021</ArticleId><ArticleId IdType="pmc">PMC8112008</ArticleId><ArticleId IdType="pubmed">33958433</ArticleId></ArticleIdList></Reference><Reference><Citation>De Meirleir KL, Mijatovic T, Subramanian K, et al. . Evaluation of four clinical laboratory parameters for the diagnosis of myalgic encephalomyelitis. J Transl Med 2018; 16: 322. doi:10.1186/s12967-018-1696-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1696-z</ArticleId><ArticleId IdType="pmc">PMC6249861</ArticleId><ArticleId IdType="pubmed">30463572</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyer DP, Pallas K, Medina-Ruiz L, et al. . CXCR2 deficient mice display macrophage-dependent exaggerated acute inflammatory responses. Sci Rep 2017; 7: 42681. doi:10.1038/srep42681</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep42681</ArticleId><ArticleId IdType="pmc">PMC5311995</ArticleId><ArticleId IdType="pubmed">28205614</ArticleId></ArticleIdList></Reference><Reference><Citation>Redente EF, Keith RC, Janssen W, et al. . Tumor necrosis factor-&#x3b1; accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages. Am J Respir Cell Mol Biol 2014; 50: 825&#x2013;837. doi:10.1165/rcmb.2013-0386OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2013-0386OC</ArticleId><ArticleId IdType="pmc">PMC4068926</ArticleId><ArticleId IdType="pubmed">24325577</ArticleId></ArticleIdList></Reference><Reference><Citation>Brauns E, Azouz A, Grimaldi D, et al. . Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients. JCI Insight 2022; 7: e154183. doi:10.1172/jci.insight.154183</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.154183</ArticleId><ArticleId IdType="pmc">PMC9090263</ArticleId><ArticleId IdType="pubmed">35380990</ArticleId></ArticleIdList></Reference><Reference><Citation>Son K, Jamil R, Chowdhury A, et al. . Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms. Eur Respir J 2023; 61: 2200970. doi:10.1183/13993003.00970-2022</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00970-2022</ArticleId><ArticleId IdType="pmc">PMC9515477</ArticleId><ArticleId IdType="pubmed">36137590</ArticleId></ArticleIdList></Reference><Reference><Citation>You M, Chen L, Zhang D, et al. . Single-cell epigenomic landscape of peripheral immune cells reveals establishment of trained immunity in individuals convalescing from COVID-19. Nat Cell Biol 2021; 23: 620&#x2013;630. doi:10.1038/s41556f-021-00690-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556f-021-00690-1</ArticleId><ArticleId IdType="pmc">PMC9105401</ArticleId><ArticleId IdType="pubmed">34108657</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohnacker S, Hartung F, Henkel F, et al. . Mild COVID-19 imprints a long-term inflammatory eicosanoid- and chemokine memory in monocyte-derived macrophages. Mucosal Immunol 2022; 15: 515&#x2013;524. doi:10.1038/s41385-021-00482-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-021-00482-8</ArticleId><ArticleId IdType="pmc">PMC9038526</ArticleId><ArticleId IdType="pubmed">35288643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>